pneumococcal conjugate vaccines
Recently Published Documents

TOTAL DOCUMENTS

434
(FIVE YEARS 105)

H-INDEX

41
(FIVE YEARS 6)
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

2022 ◽  
Vol 28 (1) ◽  
Author(s):  
Germaine Hanquet ◽  
Pavla Krizova ◽  
Tina Dalby ◽  
Shamez N. Ladhani ◽  
J. Pekka Nuorti ◽  
...  
Keyword(s):  
Conjugate Vaccines ◽  
Pneumococcal Conjugate Vaccines ◽  
Serotype Replacement

The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants

Vaccine ◽  
2021 ◽  
Author(s):  
Yaniv Faingelernt ◽  
Ron Dagan ◽  
Noga Givon-Lavi ◽  
Bart Adriaan van der Beek ◽  
Shalom Ben-Shimol ◽  
...  
Keyword(s):  
Conjugate Vaccines ◽  
Pneumococcal Conjugate Vaccines ◽  
The Impact

scholarly journals Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3

2021 ◽  
Author(s):  
Rachelle Babb ◽  
Christopher R. Doyle ◽  
Liise-anne Pirofski
Keyword(s):  
Monoclonal Antibodies ◽  
Vaccine Efficacy ◽  
Capsular Polysaccharide ◽  
Morbidity And Mortality ◽  
Human Monoclonal Antibodies ◽  
Conjugate Vaccines ◽  
Pneumococcal Conjugate Vaccines ◽  
Isolation And Characterization

Despite the global success of vaccination with pneumococcal conjugate vaccines, serotype 3 (ST3) pneumococcus remains a leading cause of morbidity and mortality. In comparison to other vaccine-included serotypes, the ST3 pneumococcal capsular polysaccharide (PPS3) induces a weaker opsonophagocytic response, which is considered a correlate of vaccine efficacy.

Load More ...
Sign in / Sign up

Export Citation Format

Share Document